Tomoyuki Kunishima
About
Tomoyuki Kunishima is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Tomoyuki Kunishima has authored 49 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tomoyuki Kunishima's work include Lipoproteins and Cardiovascular Health (18 papers), Coronary Interventions and Diagnostics (17 papers) and Cardiac Imaging and Diagnostics (15 papers). Tomoyuki Kunishima is often cited by papers focused on Lipoproteins and Cardiovascular Health (18 papers), Coronary Interventions and Diagnostics (17 papers) and Cardiac Imaging and Diagnostics (15 papers). Tomoyuki Kunishima collaborates with scholars based in Japan, United States and Sweden. Tomoyuki Kunishima's co-authors include Kiyoshi Hibi, Ichiro Michishita, Tsuyoshi Nozue, Shinichi Tohyama, Shigeo Umezawa, Shingo Yamamoto, Mitsuyasu Terashima, Takao Yamauchi, Kazuki Fukui and Yoshihiro Morino and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.
In The Last Decade
Tomoyuki Kunishima
47 papers receiving 574 citations
Peers
Tomoyuki Kunishima
Shigeo Umezawa Japan
Toshiyuki Niki Japan
Soichiro Kumagai Japan
Anna M. Pierdomenico Italy
Takeshi Tobiume Japan
Akihide Konishi Japan
Tsuyoshi Osue Japan
J.‐C. Tardif Canada
Vahid Nabavi United States
Giovanni Maria Vescovo Italy
Citations per year, relative to Tomoyuki Kunishima Tomoyuki Kunishima (= 1×)
peers
Shigeo Umezawa
Countries citing papers authored by Tomoyuki Kunishima
Since
Specialization
Citations
This map shows the geographic impact of Tomoyuki Kunishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Kunishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Kunishima more than expected).
Fields of papers citing papers by Tomoyuki Kunishima
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Tomoyuki Kunishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Kunishima. The network helps show where Tomoyuki Kunishima may publish in the future.
Co-authorship network of co-authors of Tomoyuki Kunishima
This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Kunishima. A scholar is included among the top collaborators of Tomoyuki Kunishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Kunishima. Tomoyuki Kunishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sakai, Hiroyuki, Nobuo Hatori, Tomoyuki Kunishima, et al.. (2022). Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry. Journal of Cardiology. 81(4). 385–389.
2.
Yoneyama, Kihei, Yuki Ishibashi, Tomonori Itoh, et al.. (2021). Association between acute myocardial infarction-to-cardiac rupture time and in-hospital mortality risk: a retrospective analysis of multicenter registry data from the Cardiovascular Research Consortium-8 Universities (CIRC-8U). Heart and Vessels. 36(6). 782–789.
3.
Matsuba, Ikuro, Nobuo Hatori, Yoshiyuki Watanabe, et al.. (2020). Survey of the current status of subclinical coronavirus disease 2019 (COVID-19). Journal of Infection and Chemotherapy. 26(12). 1294–1300.
4.
Sakai, Hiroyuki, Tomoyuki Kunishima, Nobuo Hatori, et al.. (2016). Rationale and design of ASSAF‐K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa). Journal of Arrhythmia. 33(2). 111–116.
5.
Nozue, Tsuyoshi, Kazuki Fukui, Yutaka Koyama, et al.. (2015). Abstract 11806: Not Glycemic Control Using Sitagliptin But Lipid Control is Associated With Change in Coronary Atherosclerosis in Patients With Type 2 Diabetes -A Serial Integrated Backscatter Intravascular Ultrasound Study. Circulation. 132(suppl_3).
6.
Nozue, Tsuyoshi, Kazuki Fukui, Yutaka Koyama, et al.. (2015). Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study. Heart and Vessels. 31(5). 649–654.
7.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2014). Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris. Lipids in Health and Disease. 13(1). 59–59.
8.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2014). Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy. Coronary Artery Disease. 25(4). 343–348.
9.
Nozue, Tsuyoshi, Sho‐ichi Yamagishi, Tsutomu Hirano, et al.. (2014). Pigment epithelium-derived factor is associated with necrotic core progression during statin therapy. Coronary Artery Disease. 26(2). 107–113.
10.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2013). Comparison of Effects of Serum n-3 to n-6 Polyunsaturated Fatty Acid Ratios on Coronary Atherosclerosis in Patients Treated With Pitavastatin or Pravastatin Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology. 111(11). 1570–1575.
11.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2013). Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound. Heart and Vessels. 30(1). 36–44.
12.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2013). Comparison of Change in Coronary Atherosclerosis in Patients With Stable Versus Unstable Angina Pectoris Receiving Statin Therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] Study). The American Journal of Cardiology. 111(7). 923–929.
13.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2013). Impacts of age on coronary atherosclerosis and vascular response to statin therapy. Heart and Vessels. 29(4). 456–463.
14.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2012). Effects of Serum n-3 to n-6 Polyunsaturated Fatty Acids Ratios on Coronary Atherosclerosis in Statin-Treated Patients With Coronary Artery Disease. The American Journal of Cardiology. 111(1). 6–11.
15.
Nozue, Tsuyoshi, Shingo Yamamoto, Shinichi Tohyama, et al.. (2012). Comparison of Arterial Remodeling and Changes in Plaque Composition Between Patients With Progression Versus Regression of Coronary Atherosclerosis During Statin Therapy (from the TRUTH Study). The American Journal of Cardiology. 109(9). 1247–1253.
16.
Nozue, Tsuyoshi, Kazuki Fukui, Kiyoshi Hibi, et al.. (2012). TCT-260 Coronary Artery Plaque Regression and Change in Plaque Composition Associated with Statin Therapy Extend for a Long-Term -Results from the Extended TRUTH Study–. Journal of the American College of Cardiology. 60(17). B74–B74.
17.
Hayami, Noriyuki, et al.. (2008). ヒト心房性ナトリウム利尿ペプチドは,ウサギのTorsades de Pointesを抑制する. Circulation. 72(5). 820–824.
18.
Akashi, Yoshihiro J., Yuji Yamamoto, Yuka Mizusawa, et al.. (2003). Significance of Plasma Brain Natriuretic Peptide in Patients with Reversible Left Ventricular Dysfunction takotsubo Cardiomyopathy. Japanese Circulation Journal-english Edition. 67. 567.
19.
Kunishima, Tomoyuki, Haruki Musha, Fumihiko Eto, et al.. (1997). A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation. Clinical Therapeutics. 19(5). 1058–1066.
20.
Kunishima, Tomoyuki. (1993). [Ultrastructural and biochemical enzymatic properties of right ventricular muscles during hindlimb suspension in rats].. PubMed. 55(4). 153–64.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shigeo Umezawa Breakdown of academic impact, for papers by Toshiyuki Niki Breakdown of academic impact, for papers by Soichiro Kumagai Breakdown of academic impact, for papers by Anna M. Pierdomenico Breakdown of academic impact, for papers by Takeshi Tobiume Breakdown of academic impact, for papers by Akihide Konishi Breakdown of academic impact, for papers by Tsuyoshi Osue Breakdown of academic impact, for papers by J.‐C. Tardif Breakdown of academic impact, for papers by Vahid Nabavi Breakdown of academic impact, for papers by Giovanni Maria Vescovo